Navigation Links
HealthSouth Reports Results for Third Quarter Ended September 30, 2008
Date:11/4/2008

40.6 48.7

Accrued expenses and other current

liabilities 360.7 364.2

Government, class action, and related

settlements 367.7 400.7

Current liabilities held for sale 35.1 88.6

Total current liabilities 860.1 970.5

Long-term debt, net of current

portion 1,820.8 1,974.4

Liabilities held for sale 3.7 4.2

Other long-term liabilities 170.0 171.4

2,854.6 3,120.5

Commitments and contingencies

Minority interest in equity of

consolidated affiliates 84.7 97.2

Convertible perpetual preferred stock 387.4 387.4

Shareholders' deficit:

Total shareholders' deficit (1,346.2) (1,554.5)

Total liabilities and shareholders'

deficit $1,980.5 $2,050.6

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows

Nine Months Ended

September 30,

2008 2007

(In Millions)

Net cash provided by (used in)

operating activities $149.3 $(139.1)

Net cash (used in) provided by

investing activities (11.9) 1,187.9

Net cash used in financing activities (133.4) (1,073.3)

Effect of exchange rate changes on

cash and cash
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Corporation Appoints New Member to Board of Directors
3. HealthSouth Announces Date of Third Quarter Earnings Conference Call
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
6. HealthSouth Issues Statement on Medicare Bill and 75% Rule
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
10. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
11. HealthSouth Announces Date of 2008 First Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... N.J., Dec. 16 Smart Balance, Inc. (Nasdaq: ... directors has authorized a two-year stock repurchase program of ... "The repurchase program demonstrates the confidence we have in ... to deliver long-term value for all of our shareholders, ... funds," said Stephen Hughes, Smart Balance, Inc. Chairman and ...
(Date:12/16/2009)... year in the United States, 160,000 cases of colorectal ... disease, making it the second leading cause of death ... researchers and clinicians fervently look for causes and cures ... producing more and more promising results Dr. Sanford ... Case Western Reserve University School of Medicine and oncologist ...
(Date:12/16/2009)... never felt so good for "The Biggest Loser" Danny ... continuing to make smart choices everyday to help him ... choice that is an important part of living well. ... glass of milk has nine essential nutrients like protein ... pressure, and calcium and vitamin D for strong bones. ...
(Date:12/16/2009)... --The most widely used human embryonic stem cell lines ... questions that must be addressed to ensure that all ... to a University of Michigan research team. ,, In ... team analyzed 47 embryonic stem cell lines, including most ... The scientists determined the genetic ancestry of each line ...
(Date:12/16/2009)... attack is long-term goal, researchers say , , WEDNESDAY, ... tool to predict whether a patient will suffer a ... , "This is an important new tool because studies ... soon after a first stroke are more likely to ... Massachusetts General Hospital and Harvard Medical School, said in ...
Breaking Medicine News(10 mins):Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Stroke Tool May Predict Early Recurrence 2
... by researchers at the University of Minnesota Medical School, have ... food are more likely to have unhealthy eating habits, //poor ... for obesity. The study results were published in the ... Study finds that the home food environment of families who ...
... 17 states will make space for a new entrant, The ... to buy the right kind of food. //The novel rainbow-colored ... one of the strategies by the U.S government, to encourage ... pyramid guide which had made the internet its home has ...
... violence, and health care disparities are among the issues ... Nursing (JHUSON) are exploring in efforts to care for ... of audiences. ,Sick at Heart —JHUSON Associate Professor ... of 'moral distress' experienced by many nurses, including those ...
... Michael Lim, M.D., assistant professor of internal medicine at ... to be on guard //after a heart attack for ... in 10 heart attack patients and kills nearly half ... is caused by a decreased pumping ability of the ...
... patients between the ages of 55 and 64 in the ... surgeries in 2004—a nearly 2,000 percent increase, according to a ... ,The report, the latest of several studies that ... percent increase in surgeries among patients age 18 to 54. ...
... that anger and hostility, in and of themselves, can increase ... has included women. // ,Results of a new ... hostility alone are not predictive for coronary artery disease in ... increased risk if they also have any of several other ...
Other Medicine News:Health News:Fast Food Limits Healthy Food Intake, Increases Obesity Risk 2Health News:Nurses Ease the Wounded Heart 2Health News:Nurses Ease the Wounded Heart 3Health News:Nurses Ease the Wounded Heart 4Health News:Obesity Surgeries Have Jumped Dramatically Since 1998 2Health News:Outwardly Expressed Anger Affects Some Women’s Heart Arterie 2
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... VIEW, Calif., Dec. 16 Frost ... Zachary Bujnoch, looks forward to speaking at ... Summit taking place on January 9, 2010 ... on the emerging market of consumer-based digital ... services. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, ...
(Date:12/16/2009)... Ill., Dec. 16 Naurex Inc., a ... depression and other CNS disorders based on its ... data presented at a major medical meeting showed ... and anxiolytic-like activity with no signs of the ... the NMDA receptor(1). The studies also showed ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6When Viruses 28Including H1N1 29 and Bacteria are as Close as your Fingertips 3B VirWalls New Innovation Can Disarm Killer Keyboards 6324 1When Viruses 28Including H1N1 29 and Bacteria are as Close as your Fingertips 3B VirWalls New Innovation Can Disarm Killer Keyboards 6324 2The Cancer Pain Drug Market Driven by the Continued Dominance of Opioids Will Increase From 242 3 Billion in 2008 to 243 7 Billion in 2018 6320 1The Cancer Pain Drug Market Driven by the Continued Dominance of Opioids Will Increase From 242 3 Billion in 2008 to 243 7 Billion in 2018 6320 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 1Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 3
... 30 The Laboratory Response Network (LRN), the national ... emergencies, will mark its first decade at its national ... by the Association of Public Health Laboratories (APHL), the ... Federal Bureau of Investigation (FBI) to test for agents ...
... Company preparing to initiate phase III trial -SOUTH SAN ... announced top-line results from their phase II study of ... The data was presented on March 27th at the ... of Medical Genetics by Brendan Lee, M.D., Ph.D., Howard ...
Other Medicine Technology:Nation's Laboratory Response Network Marks First Decade of Protecting Public Health 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 3Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 4
The computer-optimized optical design produces large, brilliant images of high resolution....
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Medicine Products: